Leading Financial Service Provider in India | Canara Bank Securities Ltd

Fredun Pharmaceuticals Ltd.

Jun 06 BSE 728.95 ( -1.65 -0.23%)

Volume15965

Prev. Close
730.60

Open Price
736.00

Today's Low / High

721.00 739.80

Bid. Price (Qty.)0.00 (0)

Offer Price (Qty.)
0.00 (0)

52 Wk Low / High

635.00 955.50

Fredun Pharmaceuticals Ltd.is not traded in NSE

Market Cap. ( ₹ in Cr. )	344.19	P/BV	2.63	Book Value ( ₹ )	277.17
52 Week High/Low ( ₹ )	956/635	FV/ML	10/1	P/E(X)	16.54
Book Closure	30/09/2024	EPS ( ₹ )	44.07	Div Yield (%)	0.10

Standalone

(₹ in Crs.)

Particulars	Dec 24	Dec 23	Dec 22	Dec 21	Dec 20
Net Sales/Income from operations	286.27	229.36	194.61	152.29	90.43
Total Income From Operations	286.27	229.36	194.61	152.29	90.43

EXPENDITURE
Consumption of Raw Materials	197.56	191.94	177.74	145.13	63.34
Increase/Decrease in Stocks	7.28	-20.54	-24.42	-22.81	6.91
Employees Cost	12.53	8.60	7.52	7.20	6.19
Depreciation	3.20	2.84	2.11	1.57	1.49
Other Expenses	33.83	23.30	17.88	14.70	8.75
Total Expenses	254.40	206.15	180.83	145.79	86.68

P/L Before Other Inc. , Int., Excpt. Items & Tax	31.87	23.22	13.78	6.50	3.75
Other Income	2.59	1.68	2.08	1.95	2.48
P/L Before Interest, Excpt. Items & Tax	34.46	24.89	15.86	8.46	6.23
Interest	14.23	9.28	5.72	2.95	2.87
P/L Before Exceptional Items & Tax	20.23	15.61	10.14	5.51	3.36
Exceptional Items	0.00	0.00	0.00	0.00	-1.16
P/L Before Tax	20.23	15.61	10.14	5.51	2.20
Tax	6.49	5.05	2.59	1.47	0.00
P/L After Tax from Ordinary Activities	13.74	10.56	7.55	4.04	2.20
Net Profit/Loss For the Period	13.74	10.56	7.55	4.04	2.20

Equity Share Capital	4.72	4.70	4.51	4.43	3.99
EPS Before Extra Ordinary *
Basic EPS (Rs.)	29.09	22.47	16.73	10.13	5.51
Diluted EPS (Rs.)	29.09	22.47	16.73	10.13	5.51
EPS After Extra Ordinary *
Basic EPS (Rs.)	29.09	22.47	16.73	10.13	5.51
Diluted EPS (Rs.)	29.09	22.47	16.73	10.13	5.51

PBITOE Margin (%)	11.13	10.12	7.08	4.26	4.15
PBTE Margin (%)	7.06	6.80	5.21	3.61	3.71
PBT Margin (%)	7.06	6.80	5.21	3.61	2.43
PAT Margin (%)	4.79	4.60	3.88	2.65	2.43

Markets

Nine Months Results

NINE MONTHS RESULTS

Fredun Pharmaceuticals Ltd.